FLYTE ACTIVATES HIGH-FREQUENCY MEMORIAL DAY WEEKEND FLIGHT NETWORK TO CAPTURE SURGING NORTHEAST DEMAND

Flyte, a regional air mobility company, announced full-scale activation of its Memorial Day flight network across the Northeast corridor, deploying aircraft on high-frequency short-haul routes including NYC to Nantucket, Hamptons, and Martha's Vineyard. The company aims to capture premium travel demand during the holiday weekend surge by offering sub-one-hour flights as an alternative to congested ground travel.

05/21/2026, 8:00 AM • GlobeNewswire

FLYTE EMERGES AS DIRECT BENEFICIARY AS RISING FUEL COSTS DRIVE AIRLINE RETREAT FROM SHORT-HAUL ROUTES

Flyte, a regional air mobility subsidiary of Catheter Precision Inc. (VTAK), is expanding operations to capitalize on major airlines' strategic retreat from short-haul routes due to rising fuel costs and unfavorable economics. The company operates Cirrus Vision Jets under FAA Part 135 certification, positioning itself to fill the connectivity gap left by traditional carriers in regional markets, particularly in the Northeast.

04/20/2026, 2:50 PM • GlobeNewswire

Catheter Precision to Attend the Annual European Heart Rhythm Association Conference

Catheter Precision, Inc. (VTAK) announced its attendance at the European Heart Rhythm Association (EHRA) conference in Paris from April 12-14, 2026. The company will showcase its LockeT suture retention device, which recently received CE Mark approval, and its VIVO 3D imaging system for identifying ventricular arrhythmia origins. CEO David Jenkins highlighted the conference as an opportunity to share new data with key opinion leaders and expand product adoption in Europe.

04/08/2026, 8:00 AM • GlobeNewswire

VTAK Announces Definitive Merger Agreement to Acquire 100% of Fly Flyte Inc.

Catheter Precision (VTAK) has completed the acquisition of the remaining 80.02% equity interest in Fly Flyte Inc. from Creatd Inc. (CRTDD), achieving 100% ownership of the regional aviation operator. The transaction converts Flyte into a wholly owned operating subsidiary with certified aircraft, FAA Part 135 certification, and active revenue-generating operations, positioning VTAK as an asset-backed aviation platform with consolidated revenues and potential operating leverage.

03/10/2026, 8:00 AM • Benzinga

Catheter Precision’s LockeT Suture Retention Device to be Featured in Live Cases at ISLAA 2026

Catheter Precision, Inc. (NYSE American: VTAK) announced that its LockeT suture retention device will be featured in live procedural cases at the International Symposium of Left Atrial Appendage 2026 conference in Los Angeles. The device, a Class I FDA-registered and CE Mark-approved suture retention device for wound closure after percutaneous venous punctures, will be demonstrated to electrophysiology fellows. The company highlighted the device's benefits including cost reduction and same-day hospital discharge capability.

03/06/2026, 8:00 AM • GlobeNewswire

Catheter Precision Divests Non-Core Assets As It Shifts Focus

Catheter Precision (VTAK) announced the sale of its atherectomy catheter technologies to focus on its electrophysiology platform. The company will receive $15 million upfront, a 5% equity stake in the acquirer, and ten-year royalty payments. VTAK shares fell 5.05% to $1.61, trading significantly below key moving averages and near 52-week lows.

02/19/2026, 10:21 AM • Benzinga

VTAK Acquires 20% Interest in Creatd's Subsidiary Fly Flyte, Inc.

Catheter Precision, Inc. (NYSE:VTAK) has acquired a 20% equity interest in Fly Flyte, Inc., a subsidiary of Creatd, Inc. (OTCQB:CRTD). The transaction supports Creatd's strategy of building a portfolio of technology-enabled operating companies while maintaining Fly Flyte's operational independence. Fly Flyte provides AI-enabled regional aviation services focused on accessibility and convenience.

02/17/2026, 2:17 PM • Benzinga

Catheter Precision Enters Distribution Agreement with FuMedica AG to Bring LockeT to Switzerland

Catheter Precision has signed a strategic distribution agreement with FuMedica AG to introduce its LockeT suture retention device to hospitals and clinics across Switzerland, marking an important step in the company's European expansion strategy.

10/16/2025, 8:00 AM • GlobeNewswire

Catheter Precision, Inc. Announces Two New Patents to be Issued by USPTO

Catheter Precision announced receiving two patent allowances from the USPTO: one for ventricular arrhythmia localization using a 3D model, and another for neurostimulation devices aimed at improving cardiac ventricular function.

09/30/2025, 8:00 AM • GlobeNewswire

Catheter Precision Announces Tender Win and First Purchase Order in Croatia

Catheter Precision received its first purchase order from Dubrava University Hospital in Croatia after a successful product evaluation of its VIVO 3D imaging system for cardiac arrhythmia procedures.

09/10/2025, 8:00 AM • GlobeNewswire

Catheter Precision, Inc. Announces Effectiveness of 1-for-19 Reverse Stock Split

Catheter Precision, Inc. implemented a 1-for-19 reverse stock split, reducing its outstanding shares from 23,316,520 to approximately 1,657,640. The split became effective on August 15, 2025, and will continue trading under the VTAK symbol on NYSE American.

08/15/2025, 8:00 AM • GlobeNewswire